Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis
Maria Pia Amato(University of Florence), Lucia Moiola(Vita-Salute San Raffaele University), Vittorio Martinelli(Vita-Salute San Raffaele University), Maria Giovanna Marrosu(University of Cagliari), Valentina Zipoli(University of Florence), María Trojano(University of Bari Aldo Moro), V. Di Tommaso, Bahia Hakiki, Alessandra Lugaresi(Istituto delle Scienze Neurologiche di Bologna), Gıancarlo Comı(Casa di Cura Columbus), Emilio Portaccio(University of Florence), Rocco Totaro(San Salvatore Hospital), Damiano Paolicelli(University of Bari Aldo Moro), Laura De Giglio(Vita-Salute San Raffaele University), Francesco Patti(University of Catania), Fabio Pellegrini(Biogen (Switzerland)), Carlo Pozzilli(Sapienza University of Rome), Gianluigi Mancardi(Istituti Clinici Scientifici Maugeri), Claudio Solaro(Rina Services (Italy)), Angelo Ghezzi, M. R. Tola(Vita-Salute San Raffaele University)
Cited by 150
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k